DarioHealth Corp. (DRIO)
6.20
-0.26
(-4.02%)
USD |
NASDAQ |
Oct 05, 12:01
DarioHealth EPS Diluted (Quarterly) : -0.8481 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8481 |
| March 31, 2026 | -1.253 |
| December 31, 2025 | -2.332 |
| September 30, 2025 | -3.052 |
| June 30, 2025 | -3.942 |
| March 31, 2025 | -0.2969 |
| December 31, 2024 | -5.101 |
| September 30, 2024 | -0.2453 |
| June 30, 2024 | -0.0846 |
| March 31, 2024 | -0.2008 |
| December 31, 2023 | -0.4413 |
| September 30, 2023 | -0.4926 |
| June 30, 2023 | -0.5796 |
| March 31, 2023 | -0.4508 |
| December 31, 2022 | -0.5295 |
| September 30, 2022 | -0.6804 |
| June 30, 2022 | -0.8039 |
| March 31, 2022 | -0.834 |
| December 31, 2021 | -1.332 |
| September 30, 2021 | -27.25 |
| June 30, 2021 | -22.64 |
| March 31, 2021 | -1.106 |
| December 31, 2020 | -1.190 |
| September 30, 2020 | -1.021 |
| June 30, 2020 | -1.163 |
| Date | Value |
|---|---|
| March 31, 2020 | -3.613 |
| December 31, 2019 | -3.278 |
| September 30, 2019 | -1.106 |
| June 30, 2019 | -2.532 |
| March 31, 2019 | -2.925 |
| December 31, 2018 | -2.722 |
| September 30, 2018 | -3.453 |
| June 30, 2018 | -6.394 |
| March 31, 2018 | -3.907 |
| December 31, 2017 | -5.002 |
| September 30, 2017 | -6.00 |
| June 30, 2017 | -171.90 |
| March 31, 2017 | -300.90 |
| December 31, 2016 | -18.34 |
| September 30, 2016 | -60.00 |
| June 30, 2016 | -292.00 |
| March 31, 2016 | -308.00 |
| December 31, 2015 | -11.48 |
| September 30, 2015 | -18.00 |
| June 30, 2015 | -25.20 |
| March 31, 2015 | -28.80 |
| December 31, 2014 | -77.26 |
| September 30, 2014 | -237.60 |
| June 30, 2014 | -270.00 |
| March 31, 2014 | -252.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Teladoc Health, Inc. | -0.2149 |
| Dogecoin Cash, Inc. | -0.0008 |
| CompuMed, Inc. | 0.0192 |
| Cannabis Strategic Ventures, Inc. | 0.00 |
| Evolent Health, Inc. | -0.252 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.924M |
| Revenue (Quarterly) | 5.177M |
| Total Expenses (Quarterly) | 13.10M |
| Enterprise Value | 65.59M |
| Gross Profit Margin (Quarterly) | 61.66% |
| Profit Margin (Quarterly) | -153.1% |
| Earnings Yield | -120.7% |
| Normalized Earnings Yield | -122.60 |